Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial (Q46542092)
Jump to navigation
Jump to search
scientific article published on 22 July 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial |
scientific article published on 22 July 2013 |
Statements
1 reference
Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Flavia Longo
1 reference
Calogero Lauricella
1 reference
Marina Chiara Garassino
1 reference
Olga Martelli
1 reference
Massimo Broggini
1 reference
Gabriella Farina
1 reference
Eliana Rulli
1 reference
Filippo Bianchi
1 reference
Anna Bettini
1 reference
Luca Moscetti
1 reference
Maurizio Tomirotti
1 reference
Mirko Marabese
1 reference
Monica Ganzinelli
1 reference
Irene Floriani
1 reference
Valter Torri
1 reference
Alberto Scanni
1 reference
TAILOR trialists
1 reference
22 July 2013
1 reference
14
1 reference
10
1 reference
981-988
1 reference